4.5 Article

Serum steroid profile captures metabolic phenotypes in adults with classic congenital adrenal hyperplasia

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Novel treatments for congenital adrenal hyperplasia

Mariska A. M. Schroder et al.

Summary: Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency require lifelong medical treatment to replace deficient hormones and reduce elevated adrenal androgens, with common long-term complications including gonadal dysfunction, infertility, and cardiovascular and metabolic issues. Novel therapies are needed to address chronic glucocorticoid overexposure, lack of circadian rhythm in replacement therapy, and inefficient delivery of glucocorticoids during periods of hyperandrogenism.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2022)

Review Endocrinology & Metabolism

Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management

Hedi L. Claahsen-van der Grinten et al.

Summary: Congenital adrenal hyperplasia is a group of autosomal recessive disorders affecting cortisol biosynthesis, with the most common form caused by steroid 21-hydroxylase deficiency due to mutations in CYP21A2. Recent developments include advancements in understanding steroidogenic pathways, improvements in diagnostic measurements, and exploration of alternative medications and treatments for CAH patients.

ENDOCRINE REVIEWS (2022)

Review Endocrinology & Metabolism

Management challenges and therapeutic advances in congenital adrenal hyperplasia

Ashwini Mallappa et al.

Summary: This review focuses on challenges and advances in managing and treating CAH due to 21-hydroxylase deficiency. New therapeutic developments include novel glucocorticoid therapies and agents aimed at controlling excess androgens. The complexity arises from disease-related hormonal derangements and treatment-related adverse effects, impacting clinical outcomes and necessitating alternative treatment approaches for improved patient outcomes.

NATURE REVIEWS ENDOCRINOLOGY (2022)

Article Endocrinology & Metabolism

Epidemiology and Long-Term Adverse Outcomes in Korean Patients with Congenital Adrenal Hyperplasia: A Nationwide Study

Jung Hee Kim et al.

Summary: Our study reveals a recent decline in the incidence of CAH in Korea. CAH patients are at higher risk for cardiovascular, metabolic, skeletal, and psychiatric disorders. Lifelong management of comorbidity risk is essential for treating CAH patients.

ENDOCRINOLOGY AND METABOLISM (2022)

Article Endocrinology & Metabolism

Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia

Ahmed Torky et al.

Summary: Patients with CAH have a higher prevalence of obesity, hypertension, insulin resistance, fasting hyperglycemia, and dyslipidemia during childhood and adulthood compared to the general US population, indicating an early onset of metabolic morbidity in this population. Treatment-related and familial factors play a role in the development of these metabolic conditions.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Seung Gyun Lim et al.

Summary: The lack of long-term outcome studies in Asian adults with classic CAH due to 21-hydroxylase deficiency prompted this research. The findings demonstrate that adults with CAH have a higher metabolic risk compared to their age- and sex-matched controls, with significantly higher rates of hypertension and obesity observed. Additionally, factors such as TARTs in men and irregular menstruation in women were also examined, revealing a correlation with hormonal levels.

FRONTIERS IN ENDOCRINOLOGY (2021)

Article Biochemistry & Molecular Biology

11-oxygenated androgens and their relation to hypothalamus-pituitary-gonadal-axis disturbances in adults with congenital adrenal hyperplasia

Matthias K. Auer et al.

Summary: In patients with classic CAH, disturbances in the hypothalamus-pituitary-gonadal (HPG)-axis are common, with elevated 11-oxygenated androgens identified in women with menstrual disturbances and men with hypogonadotropic hypogonadism. However, it remains unclear if measuring 11-oxygenated androgens is more effective than conventional markers in assessing androgen control in these patients.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2021)

Article Biochemistry & Molecular Biology

Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Luisa Paizoni et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)

Article Biochemistry & Molecular Biology

Selective LC-MRM/SIM-MS based profiling of adrenal steroids reveals metabolic signatures of 17α-hydroxylase deficiency

Chaelin Lee et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)

Article Endocrinology & Metabolism

Glucocorticoid Activity of Adrenal Steroid Precursors in Untreated Patients With Congenital Adrenal Hyperplasia

Manon Engels et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Editorial Material Endocrinology & Metabolism

Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol

Walter L. Miller

HORMONE RESEARCH IN PAEDIATRICS (2019)

Article Endocrinology & Metabolism

2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea

Mi Hae Seo et al.

JOURNAL OF OBESITY & METABOLIC SYNDROME (2019)

Review Endocrinology & Metabolism

Cardiovascular and Metabolic Outcomes in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis

Shrikant Tamhane et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Endocrinology & Metabolism

Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline

Phyllis W. Speiser et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Endocrinology & Metabolism

11-Oxygenated Androgens Are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency

Adina F. Turcu et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

Article Endocrinology & Metabolism

Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency

Adina F. Turcu et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)

Article Endocrinology & Metabolism

Increased Abdominal Adiposity in Adolescents and Young Adults With Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

Mimi S. Kim et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Article Endocrinology & Metabolism

Increased Cardiovascular and Metabolic Morbidity in Patients With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study

Henrik Falhammar et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Review Endocrinology & Metabolism

Treatment and health outcomes in adults with congenital adrenal hyperplasia

Thang S. Han et al.

NATURE REVIEWS ENDOCRINOLOGY (2014)

Article Endocrinology & Metabolism

Liquid Chromatography-Tandem Mass Spectrometry Analysis of Human Adrenal Vein 19-Carbon Steroids Before and After ACTH Stimulation

Juilee Rege et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Article Endocrinology & Metabolism

Clinical Characteristics of a Cohort of 244 Patients with Congenital Adrenal Hyperplasia

Gabriela P. Finkielstain et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Review Medical Laboratory Technology

Monitoring of Therapy in Congenital Adrenal Hyperplasia

Andrew Dauber et al.

CLINICAL CHEMISTRY (2010)

Article Endocrinology & Metabolism

Health Status of Adults with Congenital Adrenal Hyperplasia: A Cohort Study of 203 Patients

Wiebke Arlt et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)

Article Endocrinology & Metabolism

Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

Deborah P. Merke

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)